FCPA Mid-Year Webinar Series: FCPA and the Pharmaceutical Industry

The final program of the series, "FCPA and the Pharmaceutical Industry," focused on implications of the Foreign Corrupt Practices Act in the pharmaceutical industry.

Topics included:

• Overview of the FCPA and the 2010 U.K. Bribery Act
• Enforcement trends and the pharmaceutical industry
• Compliance programs and third-party due diligence
• Responding to an allegation